Injectable Succinylcholine Syringes Recalled for Sterility Assurance Failure
Central Admixture Pharmacy Services Inc is recalling 3,590 succinylcholine 200 mg/10 mL syringes distributed nationwide due to lack of assurance of sterility. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for lack of assurance of sterility in an injectable drug product. No illnesses or injuries have been reported in the source. The hazard is theoretical rather than confirmed contamination, but sterility assurance is critical for injectable pharmaceuticals.
Plain-English summary
Central Admixture Pharmacy Services Inc has recalled succinylcholine 200 mg/10 mL injectable syringes (20 mg/mL) distributed nationwide. A total of 3,590 syringes are affected by this FDA Class II recall.
The recall is due to lack of assurance of sterility. Affected lot numbers expire between October 3 and October 18, 2023.
No illnesses or injuries have been reported in connection with this product.
The recalled product
- Product
- succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6011-2
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable
- Hazard
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot:17-275343
- Exp. 10/3/2023
- 17-275472
- 17-275489
- Exp.10/4/2023
- 17-275876
- Exp. 10/11/2023
- 17-275976
- 17-275985
- Exp. 10/15/2023
- 17-276204
- Exp. 10/18/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27